Liposomal Bupivacaine in Implant Based Breast Reconstruction
Status:
Terminated
Trial end date:
2017-07-01
Target enrollment:
Participant gender:
Summary
Objectives:
1. To evaluate the effect of liposomal bupivacaine on postoperative pain levels.
2. To evaluate the effect of liposomal bupivacaine on postoperative opioid consumption and
opioid related adverse events.
3. To evaluate the effect of liposomal bupivacaine on length of hospital stay.
4. To evaluate the effect of liposomal bupivacaine on patient satisfaction with
postoperative pain control.
5. To evaluate the effect of liposomal bupivacaine on overall patient satisfaction.